Diffuse panbronchiolitis in a 10-year-old boy

Miles Weinberger1, Anthony Fischer1, Simon Kao1

  • 1Departments University of Iowa, Pediatric and Radiology, Iowa City, Iowa.

Pediatric Pulmonology
|April 1, 2015
PubMed

Insights

Diffuse panbronchiolitis, a severe respiratory illness, was successfully treated in a young Korean child with early azithromycin intervention. This case highlights the potential for complete disease resolution and sustained remission in pediatric patients with prompt diagnosis and treatment.

Area of Science:

  • Pulmonology
  • Pediatric Respiratory Medicine
  • Infectious Diseases

Background:

  • Diffuse panbronchiolitis is a progressive, fatal respiratory disease primarily affecting Southeast Asian adults.
  • The etiology of diffuse panbronchiolitis remains largely unknown.
  • Typical presentations occur in adulthood, making pediatric cases exceptionally rare.

Observation:

  • A 10-year-old child of Korean descent presented with symptoms suggestive of diffuse panbronchiolitis.
  • The patient's age and ethnicity represented an atypical demographic for this condition.
  • Early diagnosis was pursued due to the uncommon presentation.

Findings:

  • The child received early treatment with azithromycin.
  • Gradual but complete resolution of diffuse panbronchiolitis was observed.
  • Sustained remission of the respiratory disease was achieved following azithromycin therapy.

Implications:

  • This case demonstrates that diffuse panbronchiolitis can occur in pediatric populations.
  • Early diagnosis and azithromycin treatment can lead to favorable outcomes, including complete resolution and remission.
  • The findings suggest azithromycin as a potential therapeutic agent for pediatric diffuse panbronchiolitis.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.4K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
752
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K